相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Addressing phenoconversion: the Achilles' heel of personalized medicine
Rashmi R. Shah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective
H. M. Jones et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Physiology-Based IVIVE Predictions of Tramadol from in Vitro Metabolism Data
Huybrecht T'jollyn et al.
PHARMACEUTICAL RESEARCH (2015)
Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine
Rashmi R. Shah et al.
DRUG METABOLISM AND DISPOSITION (2015)
Practical Considerations for Dose Selection in Pediatric Patients to Ensure Target Exposure Requirements
April M. Barbour et al.
AAPS JOURNAL (2014)
Neonatal Livers: A Source for the Isolation of Good-Performing Hepatocytes for Cell Transplantation
Laia Tolosa et al.
CELL TRANSPLANTATION (2014)
A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data
Farzaneh Salem et al.
CLINICAL PHARMACOKINETICS (2014)
The pharmacokinetics of methadone and its metabolites in neonates, infants, and children
Robert M. Ward et al.
PEDIATRIC ANESTHESIA (2014)
Pediatric Drug Formulations: A Review of Challenges and Progress
Verica Ivanovska et al.
PEDIATRICS (2014)
Simultaneous Quantification of the Abundance of Several Cytochrome P450 and Uridine 5′-Diphospho-Glucuronosyltransferase Enzymes in Human Liver Microsomes Using Multiplexed Targeted Proteomics
Brahim Achour et al.
DRUG METABOLISM AND DISPOSITION (2014)
Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations
Ibrahim Ince et al.
CLINICAL PHARMACOKINETICS (2013)
CYP2A6 Genotype but not Age Determines Cotinine Half-Life in Infants and Children
D. A. Dempsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology
Chunnuan Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children
R. N. Hines
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Determining Population and Developmental Pharmacokinetics of Metronidazole Using Plasma and Dried Blood Spot Samples From Premature Infants
Michael Cohen-Wolkowiez et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
CYP2B6 Pharmacogenetics-Based In Vitro-In Vivo Extrapolation of Efavirenz Clearance by Physiologically Based Pharmacokinetic Modeling
Cong Xu et al.
DRUG METABOLISM AND DISPOSITION (2013)
The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity (Low Km) Catalyst
Robin E. Pearce et al.
DRUG METABOLISM AND DISPOSITION (2013)
Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6
Sarah Gadel et al.
DRUG METABOLISM AND DISPOSITION (2013)
Physiologically Based Pharmacokinetic (PBPK) Modeling in Children
J. S. Barrett et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials
R. Leong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers
Barbara Gawronska-Szklarz et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz
Wiete Kromdijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Critical Illness Is a Major Determinant of Midazolam Clearance in Children Aged 1 Month to 17 Years
Ibrahim Ince et al.
THERAPEUTIC DRUG MONITORING (2012)
Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension
Jean-Luc Vachiery et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimal and Noninvasive Probes for Hepatic and First-Pass CYP3A Induction
E. D. Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice
Stefan Lundeberg et al.
PEDIATRIC ANESTHESIA (2011)
Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential Effect
Gregory L. Kearns et al.
DRUG METABOLISM AND DISPOSITION (2010)
Human Liver Expression of CYP2C8: Gender, Age, and Genotype Effects
Suresh Babu Naraharisetti et al.
DRUG METABOLISM AND DISPOSITION (2010)
Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors
Nael Al Koudsi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)
Robert M. Ward et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Human hepatic CYP2B6 developmental expression: The impact of age and genotype
Edward L. Croom et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients
Geraldine Pettersen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A
Sandrine Turpault et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Population Pharmacokinetics of Sildenafil in Term Neonates: Evidence of Rapid Maturation of Metabolic Clearance in the Early Postnatal Period
A. Mukherjee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Role of NADPH-Cytochrome P450 Reductase and Cytochrome-b(5)/NADH-b(5) Reductase in Variability of CYP3A Activity in Human Liver Microsomes
Lu Gan et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Simcyp® Population-based ADME Simulator
Masoud Jamei et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liver
Elmar Langenfeld et al.
PROTEOMICS (2009)
Effect of CYP2C19*2 and*17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
Nicole G. Hunfeld et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Developmental changes in human liver CYP2D6 expression
Jeffrey C. Stevens et al.
DRUG METABOLISM AND DISPOSITION (2008)
Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children
U. Wintergerst et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis
Gregory L. Kearns et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Single-Dose Pharmacokinetics of Oral and Intravenous Pantoprazole in Children and Adolescents
Gregory L. Kearns et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Caffeine Citrate Treatment for Extremely Premature Infants With Apnea: Population Pharmacokinetics, Absolute Bioavailability, and Implications for Therapeutic Drug Monitoring
Bruce G. Charles et al.
THERAPEUTIC DRUG MONITORING (2008)
Ontogeny of dextromethorphan O- and N-demethylation in the first year of life
M. J. Blake et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants
Michael J. Blake et al.
PEDIATRIC RESEARCH (2006)
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
Neal L. Benowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Simultaneous measurement of in vivo P-glycoprotein and cytochrome P450 3A activities
Brian Kirby et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Population pharmacokinetic/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics
Maria J. Garrido et al.
PHARMACEUTICAL RESEARCH (2006)
Pharmacokinetics and safety of montelukast in children aged 3 to 6 months
Barbara Knorr et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacokinetic changes in critical illness
Bradley A. Boucher et al.
CRITICAL CARE CLINICS (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Use of tolterodine in children with neurogenic detrusor overactivity: Relationship between dose and urodynamic response
PI Ellsworth et al.
JOURNAL OF UROLOGY (2005)
Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants
AT Bösenberg et al.
PEDIATRIC ANESTHESIA (2005)
Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model:: Model development and evaluation and derivation of analytical solutions for ka and Fa
HH Usansky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
A population pharmacokinetic model for montelukast disposition in adults and children
R Ramakrishnan et al.
PHARMACEUTICAL RESEARCH (2005)
Clinical consequences of cytochrome P4502C9 polymorphisms
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Cyclophosphamide metabolism in children with non-Hodgkin's lymphoma
SM Yule et al.
CLINICAL CANCER RESEARCH (2004)
Topological changes in the CYP3A4 active site probed with phenyldiazene: Effect of interaction with NADPH-cytochrome P450 reductase and cytochrome B5 and of site-directed mutagenesis
Y Yamaguchi et al.
DRUG METABOLISM AND DISPOSITION (2004)
Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes
MT Donato et al.
DRUG METABOLISM AND DISPOSITION (2004)
Clinical pharmacology of tramadol
S Grond et al.
CLINICAL PHARMACOKINETICS (2004)
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
JG Gerber et al.
CHIRALITY (2004)
Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old
E Migoya et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Human hepatic CYP2E1 expression during development
EK Johnsrud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients
SN de Wildt et al.
CRITICAL CARE MEDICINE (2003)
In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally
LJ Van Obbergh et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2003)
Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients
H Takahashi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Developmental expression of the major human hepatic CYP3A enzymes
JC Stevens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data
F Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children
A Tran et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency
M Haubitz et al.
KIDNEY INTERNATIONAL (2002)
Pharmacokinetics and metabolism of oral midazolam in preterm infants
SN de Wildt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration
MD Reed et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Pharmacokinetics and metabolism of intravenous midazolam in preterm infants
SN de Wildt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
UM Zanger et al.
PHARMACOGENETICS (2001)
The pharmacokinetics of epidural ropivacaine in infants and young children
ME McCann et al.
ANESTHESIA AND ANALGESIA (2001)
A double-blind, randomized comparison of IV lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model
J Barr et al.
ANESTHESIOLOGY (2001)
Intravenous omeprazole in children: Pharmacokinetics and effect on 24-hour intragastric pH
C Faure et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2001)
Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction
GM Ferron et al.
CLINICAL THERAPEUTICS (2001)
Montelukast dose selection in children ages 2 to 5 years: Comparison of population pharmacokinetics between children and adults
B Knorr et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis
TN Johnson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Analgesic efficacy of tramadol 2 mg kg-1 for paediatric day-case adenoidectomy
H Viitanen et al.
BRITISH JOURNAL OF ANAESTHESIA (2001)
Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children
H Takahashi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Ropivacaine pharmacokinetics after caudal block in 1-8 year old children
PA Lönnqvist et al.
BRITISH JOURNAL OF ANAESTHESIA (2000)
Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide
ZQ Huang et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Nicotine metabolism and elimination kinetics in newborns
D Dempsey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor
OO Akinyinka et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians
OO Akinyinka et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
